Andrea Newkirk
Stock Analyst at Goldman Sachs
(2.95)
# 1,316
Out of 5,165 analysts
4
Total ratings
66.67%
Success rate
83.73%
Average return
Main Sectors:
Stocks Rated by Andrea Newkirk
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Initiates: Neutral | $19 | $12.29 | +54.60% | 1 | Sep 30, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $65 → $73 | $99.13 | -26.36% | 2 | Sep 12, 2025 | |
| ALKS Alkermes | Initiates: Buy | $43 | $27.65 | +55.52% | 1 | Jul 15, 2025 |
Schrödinger
Sep 30, 2025
Initiates: Neutral
Price Target: $19
Current: $12.29
Upside: +54.60%
Revolution Medicines
Sep 12, 2025
Maintains: Buy
Price Target: $65 → $73
Current: $99.13
Upside: -26.36%
Alkermes
Jul 15, 2025
Initiates: Buy
Price Target: $43
Current: $27.65
Upside: +55.52%